DTC ads for Vaniqa cream are awaiting final approval

Published on .

Branded direct-to-consumer TV and print ads for Vaniqa are awaiting clearance by either its marketers or the U.S. Food & Drug Administration or both, according to a Bristol-Myers Squibb Co. spokeswoman. The new prescription cream for unwanted facial hair in women is being co-marketed by Bristol-Myers and the Gillette Co. DDB Corbett, Chicago, handles.

Copyright September 2000, Crain Communications Inc.

Most Popular
In this article: